Slayback Pharma LLC, a United States-based specialty pharmaceutical company, announced on Friday that it has named Paul Campanelli as its new director.

Campanelli is the chairman of Endo Pharmaceuticals, and was most recently president and CEO of Endo Pharmaceuticals. He has held the positions of CEO, COO and president of Par Pharmaceutical Companies Inc. He was also vice president, Business Development at Dr Reddy's Laboratories Ltd.

Ajay Singh, Slayback Pharma president & CEO, said, 'Not only is Paul a widely respected industry veteran, but I also personally have great admiration for Paul's track record in building, growing and running Par Pharmaceuticals and later the combined Endo-Par house through its numerous stages of growth and challenges. It takes decades to build and grow an organisation and Paul did precisely that--leading from the front for two decades. Paul has been a general and yet also a soldier fighting in the trenches. Even today, he can roll up his sleeves and dive into a product discussion. Additionally, Paul's ability to 'connect the dots' across the entire spectrum of the pharmaceutical value chain is second to none. His skills, experience and personality are all a perfect fit for Slayback as we navigate our trajectory through an important and exciting phase of growth. I am absolutely delighted to have Paul join our Board and help Slayback through its next chapter.'